![](/img/cover-not-exists.png)
PCN95 COST-EFFECTIVENESS OF SEROTONIN-TYPE 3 RECEPTOR ANTAGONISTS FOR CHEMOTHERAPY-INDUCED EMESIS IN NON SMALL CELL LUNG CANCER PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY
DC Colayco, J HayVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72184-7
File:
PDF, 68 KB
english, 2010